On March 5, 2018 Sangamo Therapeutics, Inc. (Nasdaq: SGMO) reported that Dr. Sandy Macrae, CEO of Sangamo, is scheduled to participate in the following healthcare investor conferences in March (Press release, Sangamo Therapeutics, MAR 5, 2018, View Source [SID1234524396]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 38th Annual Health Care Conference, Boston, MA, March 12-14, 2018
Dr. Macrae is scheduled to present at 1:30 p.m. ET on Monday, March 12th.
Barclays 2018 Global Healthcare Conference, Miami, FL, March 13-15, 2018
Dr. Macrae is scheduled to present at 10:15 a.m. ET on Thursday, March 15th.
Sangamo Therapeutics, Inc. (PRNewsfoto/Sangamo Therapeutics, Inc.)

The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the event.